A Phase 1 clinical trial involving insulin lispro has been updated to a status of completed as of October 19, 2026. The study, titled "Intranasal Insulin and Olanzapine Study in Healthy Volunteers," is registered under identifier NCT03741478. This trial is listed as a Phase 1 study, indicating an early stage investigation. The trial status reflects that the study procedures have concluded according to the registry record. No results or outcome data are included in this update. This brief reports only the status change and basic trial details as recorded in the registry. Readers interested in insulin lispro can find additional background on the compound overview page linked with this brief.
Insulin Lispro Trial NCT03741478 Marked Completed as of Oct 19, 2026
See the full insulin lispro overview
Source: https://clinicaltrials.gov/study/NCT03741478